Bure Equity
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
Bure Equity is a Swedish investment company involved in communications, textiles, training, and education.
On February 11, 2009, Altor Fund III and Bure Equity AB signed an agreement to acquire Carnegie Investment Bank, a leading independent Nordic investment bank, from the Swedish National Debt Office.[3] The total net asset value on 31 December 2016 amounted to six billion kroner and the largest holdings were in the companies Mycronic and Vitrolife. The company also has shares in, among others, the industrial company Cavotec, the pharmaceutical company MedCap, the medical technology company Xvivo Perfusion and the auction company Lauritz.com.[4]
Henrik Blomquist took over as CEO in 2014.[5]
On 20 January, 2022, Bure sold their locomotive leasing business for an undisclosed amount. [6]
References
- ^ Corporate Information Snapshot Archived July 8, 2011, at the Wayback Machine
- Washington TimesAugust 11, 2008
- ^ "Bure - press release". Cision Wire. Archived from the original on 2012-07-30. Retrieved 2009-02-11.
- ^ "Bure - Finansiella rapporter". www.bure.se. Retrieved 2022-07-25.
- ^ "Blomquist utsedd till vd i Bure | Affärsvärlden". 2018-07-20. Archived from the original on 2018-07-20. Retrieved 2022-07-25.
- ^ "Bure Equity sells locomotive leasing business". 2022-01-24. Retrieved 2023-11-10.
External links
 | This Swedish corporation or company article is a stub. You can help Wikipedia by expanding it. |